Bronchospasm: Difference between revisions
No edit summary |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 18: | Line 18: | ||
'''Associate-editor-in-chief:''' Areej Tariq | '''Associate-editor-in-chief:''' Areej Tariq | ||
'''Bronchospasm''' is a difficulty in breathing caused by a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release ([[degranulation]]) of substances from [[mast cells]] or [[basophil]]s under the influence of [[anaphylatoxin]]s. | '''Bronchospasm''' is a difficulty in breathing caused by a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release ([[degranulation]]) of substances from [[mast cells]] or [[basophil]]s under the influence of [[anaphylatoxin]]s. | ||
| Line 65: | Line 65: | ||
*[[Zanamivir]] | *[[Zanamivir]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
Revision as of 23:12, 8 August 2012
| {{}} |
|
WikiDoc Resources for Bronchospasm |
|
Articles |
|---|
|
Most recent articles on Bronchospasm Most cited articles on Bronchospasm |
|
Media |
|
Powerpoint slides on Bronchospasm |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bronchospasm at Clinical Trials.gov Clinical Trials on Bronchospasm at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bronchospasm
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Bronchospasm Discussion groups on Bronchospasm Patient Handouts on Bronchospasm Directions to Hospitals Treating Bronchospasm Risk calculators and risk factors for Bronchospasm
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bronchospasm |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate-editor-in-chief: Areej Tariq
Bronchospasm is a difficulty in breathing caused by a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release (degranulation) of substances from mast cells or basophils under the influence of anaphylatoxins.
Bronchospasm appears as the feature of asthma, chronic bronchitis, anaphylaxis, and as a possible side-effect of the drug Pilocarpine (which is used to treat illness resulting from the ingestion of deadly nightshade as well as other things). The overactivity of the bronchioles' muscle is a result of exposure to a stimulus which under normal circumstances would cause little or no response. The resulting constriction and inflammation causes a narrowing of the airways and an increase in mucous production; this reduces the amount of oxygen that is available to the individual causing breathlessness, coughing and hypoxia (that can cause cyanosis).
Differential diagnosis of the causes of Bronchospasm
- 5-Hydroxyindoleacetic acid
- Abciximab (patient information)
- Acetylsalicylic acid
- Alemtuzumab
- Allergic bronchopulmonary aspergillosis
- Anaphylatoxin
- Aspirin
- Atenolol
- Atracurium
- Beta-blockers
- Betaxolol
- Bronchial challenge test
- Cocaine
- Colistin
- Acidosis
- Diclofenac
- Exercise Stress Testing
- Formoterol (patient information)
- Hydrogen sulfide
- Hydroxyethyl starch
- Hypomagnesemia
- Ibuprofen
- Indomethacin
- Ketamine
- Ketorolac
- Monosodium glutamate
- Nadolol
- Nitrazepam
- Non-steroidal anti-inflammatory drug
- Pentamidine
- Propafenone
- Rapacuronium
- Salmeterol oral inhalation (patient information)
- Schistosoma mansoni
- Scombroid
- Shock (medical)
- Tetrodotoxin
- Timolol
- Zanamivir